Evidence map›Paper›PMID 37158379›Full record

ArticleEMBO molecular medicine2023

The under-appreciated world of the serpin family of serine proteinase inhibitors.

Marie-Christine Bouton, Margarethe Geiger, William P Sheffield, James A Irving, David A Lomas, Sihong Song, Ritvik S Satyanarayanan, Liqiang Zhang, Grant McFadden, Alexandra R Lucas

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Serpin 4/5 ofMicroorganisms · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Crystallization and crystallographic studies of human serine protease inhibitor (serpin) B9.Acta crystallographica. Section F, Structural biology communications · 2024
    Article
  20. bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Marie-Christine BoutonUniversité Paris Cité and Université Sorbonne Paris Nord, INSERM U1148-LVTS, Paris, France.ORCID 0000-0001-5092-7363
Margarethe GeigerCenter for Physiology and Pharmacology, Department of Vascular Biology and Thrombosis Research, Medical University Vienna, Vienna, Austria.ORCID 0000-0003-2021-5319
William P SheffieldMcMaster University and Canadian Blood Services, Hamilton, ON, Canada.ORCID 0000-0002-5870-8189
James A IrvingUCLRespiratory, Division of Medicine, University College London, London, UK.ORCID 0000-0003-3204-6356
David A LomasUCLRespiratory, Division of Medicine, University College London, London, UK.ORCID 0000-0003-2339-6979
Sihong SongDepartment of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Ritvik S SatyanarayananBiomedical Engineering, Arizona State University (ASU), Tempe, AZ, USA.
Liqiang ZhangCenter for Personalized Diagnostics (CPD), Biodesign Institute, Arizona State University (ASU), Tempe, AZ, USA.
Grant McFaddenCenter for Immunotherapy, Vaccines and Virotherapy (CIVV), Biodesign Institute, Arizona State University (ASU), Tempe, AZ, USA.ORCID 0000-0002-2556-3526
Alexandra R LucasCenter for Personalized Diagnostics (CPD), Biodesign Institute, Arizona State University (ASU), Tempe, AZ, USA.ORCID 0000-0002-5195-1442
Arizona State University · USThe London College · GBCanadian Blood Services · CAInserm · FRMedical University of Vienna · ATTranslational Genomics Research Institute · USUniversity of Florida · US

Funding

Bioengineered Skin SealantsR01AR074627 · NIAMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI REGE, KAUSHAL · 2020 to 2023
$1.5M
Department of HealthMedical Research CouncilNIAMS NIH HHS R01 AR074627
6 · The paper itself

Abstract

In the practice of medicine, many fundamental biological pathways that require tight on/off control, such as inflammation and circulatory homeostasis, are regulated by serine proteinases, but we rarely consider the unique protease inhibitors that, in turn, regulate these proteases. The serpins are a family of proteins with a shared tertiary structure, whose members largely act as serine protease inhibitors, found in all forms of life, ranging from viruses, bacteria, and archaea to plants and animals. These proteins represent up to 2-10% of proteins in the human blood and are the third most common protein family.

Indexed as

SerpinsAnimalsHumansInflammationSerine ProteasesSerine Proteinase InhibitorsSerine ProteasesSerine Proteinase InhibitorsSerpins

Identifiers

PMID37158379
PMCPMC10245030
OpenAlexW4375955055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.